乳糜泻自身免疫与1型糖尿病中较低血压及肾脏风险相关
该研究基于匹兹堡儿童期发病1型糖尿病并发症流行病学研究的前瞻性随访,对618名参与者筛查组织转谷氨酰胺酶(tTG)抗体,评估乳糜泻自身免疫与25年糖尿病病程时肾脏结局的关系。结果显示,tTG强阳性或临床乳糜泻病史者(33例,5.3%)基线血压和血脂较低,且大量白蛋白尿累积发生率显著低于血清学阴性者(3.6% vs 30.0%,P=0.003),校正后仍显著(校正P=0.004),而微量白蛋白尿和终末期肾病(ESRD)无显著差异。
要点
- tTG强阳性或临床乳糜泻病史者基线血压和血脂较低。
- 25年时大量白蛋白尿累积发生率强阳性者3.6% vs 阴性者30.0%(P=0.003)。
- 微量白蛋白尿(40.0% vs 57.1%)和ESRD(0 vs 4.1%)无显著差异。
核心结论
- 儿童期发病1型糖尿病中,乳糜泻自身免疫强阳性状态与较低基线血压和胆固醇水平以及25年糖尿病病程后较低的大量白蛋白尿风险相关,且微量白蛋白尿或ESRD风险未增加。
研究设计与样本
- 匹兹堡儿童期发病1型糖尿病并发症流行病学研究的前瞻性随访,618名参与者筛查tTG抗体,肾脏结局在25年糖尿病病程时确定。
主要发现
- 33名(5.3%)tTG强阳性(≥3倍正常上限)或报告临床乳糜泻病史的受试者基线血压和血脂值较低。
- 25年糖尿病病程时,强阳性受试者大量白蛋白尿累积发生率3.6% vs 血清学阴性者30.0%(P=0.003),校正年龄、HbA1c、血脂和血压后仍显著(校正P=0.004)。
- 强阳性与tTG阴性组间微量白蛋白尿(40.0% vs 57.1%)或ESRD(0 vs 4.1%)无显著差异。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Though the long-term consequences of celiac disease (CD) in type 1 diabetes are unclear, CD has been associated with increased prevalence of end-stage renal disease (ESRD) independent of type 1 diabetes. OBJECTIVE: We evaluated whether celiac autoimmunity is related to the cumulative incidence of microalbuminuria [albumin excretion rate (AER) 20 to 200 µg/min], macroalbuminuria (AER >200 µg/min), and ESRD. DESIGN, PATIENTS, AND METHODS: In the prospective follow-up of the Pittsburgh Epidemiology of Diabetes Complications study of childhood-onset type 1 diabetes, 618 participants were screened for tissue transglutaminase (tTG) antibodies with a clinical assay. Nephropathy outcomes were determined at 25 years of diabetes duration. RESULTS: Overall, the 33 subjects (5.3%) with strongly positive tTG levels (≥3 times the upper limit of normal) or a reported clinical history of CD had lower baseline blood pressure and lipid values. At 25 years of diabetes duration, a lower cumulative incidence of macroalbuminuria in strongly positive subjects compared with those with negative serology (3.6% vs 30.0%; P = 0.003) remained significant after adjustment for age, HbA1c, lipid measures, and blood pressure (adjusted P = 0.004). No considerable differences between these subjects and tTG-negative groups were found for microalbuminuria (40.0% vs 57.1%) or ESRD (0 vs 4.1%). CONCLUSIONS: These findings show that strongly positive celiac autoimmunity status in individuals with childhood-onset type 1 diabetes is associated with lower baseline blood pressure and cholesterol measurements as well as lower macroalbuminuria risk after 25 years of type 1 diabetes duration with no increase in the risk of microalbuminuria or ESRD.
引用
- Williams KV, Cristaldi CL, Miller RG, et al. Celiac Autoimmunity Is Associated With Lower Blood Pressure and Renal Risk in Type 1 Diabetes. J Clin Endocrinol Metab. 2018. PMID: 30099548. doi:10.1210/jc.2018-00908
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。